These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 6266517

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE, Kosterlitz HW.
    Proc R Soc Lond B Biol Sci; 1979 Aug 31; 205(1160):425-32. PubMed ID: 41257
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
    Bojnik E, Magyar A, Tóth G, Bajusz S, Borsodi A, Benyhe S.
    Neuroscience; 2009 Jan 23; 158(2):867-74. PubMed ID: 18977279
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sulfonic acid enkephalin: binding specificity to rat brain opiate receptors.
    Martin JL, Coletti-Previero MA, Roques BP, Descomps B.
    Neuropeptides; 1985 Jul 23; 6(4):293-302. PubMed ID: 2995863
    [Abstract] [Full Text] [Related]

  • 29. LY164929: a highly selective ligand for the lower affinity [3H]D-Ala2-D-Leu-5-enkephalin binding site.
    Rothman RB, Bykov V, Ofri D, Rice KC.
    Neuropeptides; 1988 Jan 23; 11(1):13-6. PubMed ID: 2835701
    [Abstract] [Full Text] [Related]

  • 30. Enhancement of [3H]DAGO1 binding to rat brain by low concentrations of monovalent cations.
    Bolger GT, Marcus KA, Thibou R, Skolnick P, Weissman BA.
    Can J Physiol Pharmacol; 1987 Nov 23; 65(11):2338-45. PubMed ID: 2835135
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
    Childers SR.
    J Pharmacol Exp Ther; 1984 Sep 23; 230(3):684-91. PubMed ID: 6088761
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
    Ohlsson AE, Fu TC, Jones D, Martin BR, Dewey WL.
    J Pharmacol Exp Ther; 1982 May 23; 221(2):362-7. PubMed ID: 6281413
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Opiate receptors, endorphins and drug therapy.
    Sewell RD, Lee RL.
    Postgrad Med J; 1980 May 23; 56 Suppl 1():25-30. PubMed ID: 6248844
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Radioiodinated [D-Ala2, Met5] enkephalin. Preparation, purification by high performance liquid chromatography and binding characteristics.
    Yeung CW.
    Int J Pept Protein Res; 1984 Dec 23; 24(6):636-44. PubMed ID: 6099338
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.